Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,244.46
+2,937.68(+6.21%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

2.2400

+0.0500

(+2.28%)

At close: 04:00PM EDT

2.2100

-0.03

(-1.34%)

After hours:

05:20PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	2.62M
Enterprise value	-6.52M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.36
Enterprise value/revenue	N/A
Enterprise value/EBITDA	0.38

Trading information

Stock price history

Beta (5Y monthly)	1.38
52-week change ³	-71.04%
S&P500 52-week change ³	22.38%
52-week high ³	11.7700
52-week low ³	2.1050
50-day moving average ³	3.6531
200-day moving average ³	5.5897

Share statistics

Avg vol (3-month) ³	26.48k
Avg vol (10-day) ³	17.06k
Shares outstanding ⁵	1.17M
Implied shares outstanding ⁶	1.17M
Float ⁸	869.35k
% held by insiders ¹	25.72%
% held by institutions ¹	3.26%
Shares short (15 Apr 2024) ⁴	14.84k
Short ratio (15 Apr 2024) ⁴	0.88
Short % of float (15 Apr 2024) ⁴	1.71%
Short % of shares outstanding (15 Apr 2024) ⁴	1.27%
Shares short (prior month 15 Mar 2024) ⁴	23.86k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	01 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-55.20%
Return on equity (ttm)	-164.09%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-15.19M
Diluted EPS (ttm)	-12.9700
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	9.14M
Total cash per share (mrq)	7.8
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.25
Book value per share (mrq)	1.65

Cash flow statement

Operating cash flow (ttm)	-9.85M
Levered free cash flow (ttm)	-2.75M